Increase in demand to enhance the aesthetic beauty and growth in preference for minimally invasive procedures majorly drive the market. In addition, increase in pool of geriatric population and introduction of better facial injectable such as synthetic calcium hydroxyl apatite fillers boost the market growth. However, strict regulatory concerns of injectable products and side effects of such products such as rashes restrict the market growth.
This report on the facial injectables market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the facial injectables market.
Research Methodology
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2016 to 2026, considering the macro and micro environmental factors. Growth rates for each segment within the facial injectables market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
Market revenue in terms of US$ Mn for the period between 2016 and 2026 along with the compound annual growth rate (CAGR %) from 2019 to 2026 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as growing global obsession with physical appearance and the desire to look young and rising inclination toward minimally invasive surgeries, in historical year-on-year growth have been taken into consideration while estimating the market size.
The major key players operating in this market include Advanced Dermatology, Merz, Inc., Galderma Laboratories, L.P., ColBar LifeScience Ltd., Allergan, Plc, Valeant Pharmaceuticals North America LLC, Sanofi Biosurgery Inc., and Anika Therapeutics, Inc.
Facial Injectable Market Key Segments
By Type
By End-User
By Geography
Chapter 1 INTRODUCTION
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Chapter 2 EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
Chapter 3 MARKET OVERVIEW
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top Player Positioning/ Market Share Analysis, 2017
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
Chapter 4 FACIAL INJECTABLES MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Dermal Fillers/Injectable Implants
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Hyaluronic Acid
4.2.2.1.1. Market size and forecast
4.2.2.2. Collagen Fillers
4.2.2.2.1. Market size and forecast
4.2.2.3. Synthetic Fillers
4.2.2.3.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Anti-aging/ Anti-wrinkle Injections
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Botulinum Toxin A
4.3.2.1.1. Market size and forecast
4.3.2.2. Poly-L-Lactic Acid (PLLA)
4.3.2.2.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country
Chapter 5 FACIAL INJECTABLES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Aesthetics
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Therapeutics
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
Chapter 6 FACIAL INJECTABLES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Dermatology Clinics
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Beauty Clinics
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
6.5. Dermatology Research Institute
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country
Chapter 7 FACIAL INJECTABLES MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. North America facial injectables market, by country
7.2.2.1. U.S. facial injectables market
7.2.2.1.1. U.S. market, by product type
7.2.2.1.2. U.S. market, by application
7.2.2.1.3. U.S. market, by end user
7.2.2.2. Canada facial injectables market
7.2.2.2.1. Canada market, by product type
7.2.2.2.2. Canada market, by application
7.2.2.2.3. Canada market, by end user
7.2.2.3. Mexico facial injectables market
7.2.2.3.1. Mexico market, by product type
7.2.2.3.2. Mexico market, by application
7.2.2.3.3. Mexico market, by end user
7.2.3. North America facial injectables market, by product type
7.2.4. North America facial injectables market, by application
7.2.5. North America facial injectables market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Europe facial injectables market, by country
7.3.2.1. Germany facial injectables market
7.3.2.1.1. Germany market, by product type
7.3.2.1.2. Germany market, by application
7.3.2.1.3. Germany market, by end user
7.3.2.2. France facial injectables market
7.3.2.2.1. France market, by product type
7.3.2.2.2. France market, by application
7.3.2.2.3. France market, by end user
7.3.2.3. UK facial injectables market
7.3.2.3.1. UK market, by product type
7.3.2.3.2. UK market, by application
7.3.2.3.3. UK market, by end user
7.3.2.4. Italy facial injectables market
7.3.2.4.1. Italy market, by product type
7.3.2.4.2. Italy market, by application
7.3.2.4.3. Italy market, by end user
7.3.2.5. Spain facial injectables market
7.3.2.5.1. Spain market, by product type
7.3.2.5.2. Spain market, by application
7.3.2.5.3. Spain market, by end user
7.3.2.6. Rest of Europe facial injectables market
7.3.2.6.1. Rest of Europe market, by product type
7.3.2.6.2. Rest of Europe market, by application
7.3.2.6.3. Rest of Europe market, by end user
7.3.3. Europe facial injectables market, by product type
7.3.4. Europe facial injectables market, by application
7.3.5. Europe facial injectables market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Asia-Pacific facial injectables market, by country
7.4.2.1. Japan facial injectables market
7.4.2.1.1. Japan market, by product type
7.4.2.1.2. Japan market, by application
7.4.2.1.3. Japan market, by end user
7.4.2.2. China facial injectables market
7.4.2.2.1. China market, by product type
7.4.2.2.2. China market, by application
7.4.2.2.3. China market, by end user
7.4.2.3. India facial injectables market
7.4.2.3.1. India market, by product type
7.4.2.3.2. India market, by application
7.4.2.3.3. India market, by end user
7.4.2.4. Australia facial injectables market
7.4.2.4.1. Australia market, by product type
7.4.2.4.2. Australia market, by application
7.4.2.4.3. Australia market, by end user
7.4.2.5. Rest of Asia-Pacific facial injectables market
7.4.2.5.1. Rest of Asia-Pacific market, by product type
7.4.2.5.2. Rest of Asia-Pacific market, by application
7.4.2.5.3. Rest of Asia-Pacific market, by end user
7.4.3. Asia-Pacific facial injectables market, by product type
7.4.4. Asia-Pacific facial injectables market, by application
7.4.5. Asia-Pacific facial injectables market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. LAMEA facial injectables market, by country
7.5.2.1. Brazil facial injectables market
7.5.2.1.1. Brazil market, by product type
7.5.2.1.2. Brazil market, by application
7.5.2.1.3. Brazil market, by end user
7.5.2.2. Saudi Arabia facial injectables market
7.5.2.2.1. Saudi Arabia market, by product type
7.5.2.2.2. Saudi Arabia market, by application
7.5.2.2.3. Saudi Arabia market, by end user
7.5.2.3. South Africa facial injectables market
7.5.2.3.1. South Africa market, by product type
7.5.2.3.2. South Africa market, by application
7.5.2.3.3. South Africa market, by end user
7.5.2.4. Rest of LAMEA facial injectables market
7.5.2.4.1. Rest of LAMEA market, by product type
7.5.2.4.2. Rest of LAMEA market, by application
7.5.2.4.3. Rest of LAMEA market, by end user
7.5.3. LAMEA facial injectables market, by product type
7.5.4. LAMEA facial injectables market, by application
7.5.5. LAMEA facial injectables market, by end user
Chapter 8 COMPANY PROFILES
8.1. Allergan, Plc.
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. Anika Therapeutics, Inc.
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. Bloomage BioTechnology Corporation Limited
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. ColBar LifeScience Ltd.
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. Galderma Laboratories, L.P.
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. Medytox, Inc.
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. Ipsen
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. Merz, Inc.
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. Suneva Medical, Inc.
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. Sinclair Pharma Plc
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers